» Articles » PMID: 38404617

DECM Restores Macrophage Immune Homeostasis and Alleviates Iron Overload to Promote DTPI Healing

Overview
Journal Regen Biomater
Date 2024 Feb 26
PMID 38404617
Authors
Affiliations
Soon will be listed here.
Abstract

Due to its highly insidious and rapid progression, deep tissue pressure injury (DTPI) is a clinical challenge. Our previous study found that DTPI may be a skeletal muscle injury dominated by macrophage immune dysfunction due to excessive iron accumulation. Decellularized extracellular matrix (dECM) hydrogel promotes skeletal muscle injury repair. However, its role in polarizing macrophages and regulating iron metabolism in DTPI remains unclear. Here, porcine dECM hydrogel was prepared, and its therapeutic function and mechanism in repairing DTPI were investigated. The stimulus of dECM hydrogel toward RAW264.7 cells resulted in a significantly higher percentage of CD206 macrophages and notably decreased intracellular divalent iron levels. In mice DTPI model, dECM hydrogel treatment promoted M1 to M2 macrophage conversion, improved iron metabolism and reduced oxidative stress in the early stage of DTPI. In the remodeling phase, the dECM hydrogel remarkably enhanced revascularization and accelerated skeletal muscle repair. Furthermore, the immunomodulation of dECM hydrogels was mainly involved in the P13k/Akt signaling pathway, as revealed by GO and KEGG pathway analysis, which may ameliorate the iron deposition and promote the healing of DTPI. Our findings indicate that dECM hydrogel is promising in skeletal muscle repair, inflammation resolution and tissue injury healing by effectively restoring macrophage immune homeostasis and normalizing iron metabolism.

Citing Articles

Semi-quantitative scoring criteria based on multiple staining methods combined with machine learning to evaluate residual nuclei in decellularized matrix.

Zhong M, He H, Ni P, Huang C, Zhang T, Chen W Regen Biomater. 2025; 12:rbae147.

PMID: 39886363 PMC: 11780845. DOI: 10.1093/rb/rbae147.


3D biological scaffold delivers Bergenin to reduce neuroinflammation in rats with cerebral hemorrhage.

Zhang A, Cong L, Nan C, Zhao Z, Liu L J Transl Med. 2024; 22(1):946.

PMID: 39420402 PMC: 11484212. DOI: 10.1186/s12967-024-05735-1.


Engineered liver-derived decellularized extracellular matrix-based three-dimensional tumor constructs for enhanced drug screening efficiency.

Luo S, Wang Q, Li M, Xu P, Wang Y, Wang Y Regen Biomater. 2024; 11:rbae113.

PMID: 39350956 PMC: 11441757. DOI: 10.1093/rb/rbae113.

References
1.
Jiang Y, Liu J, Hong W, Fei X, Liu R . Arctigenin Inhibits Glioblastoma Proliferation through the AKT/mTOR Pathway and Induces Autophagy. Biomed Res Int. 2020; 2020:3542613. PMC: 7512051. DOI: 10.1155/2020/3542613. View

2.
Cui C, Ferrucci L, Gorospe M . Macrophage Involvement in Aging-Associated Skeletal Muscle Regeneration. Cells. 2023; 12(9). PMC: 10177543. DOI: 10.3390/cells12091214. View

3.
Witherel C, Abebayehu D, Barker T, Spiller K . Macrophage and Fibroblast Interactions in Biomaterial-Mediated Fibrosis. Adv Healthc Mater. 2019; 8(4):e1801451. PMC: 6415913. DOI: 10.1002/adhm.201801451. View

4.
Preston A, Rao A, Strauss R, Stamm R, Zalman D . Deep Tissue Pressure Injury: A Clinical Review. Am J Nurs. 2017; 117(5):50-57. DOI: 10.1097/01.NAJ.0000516273.66604.c7. View

5.
Sun H, Pulakat L, Anderson D . Challenges and New Therapeutic Approaches in the Management of Chronic Wounds. Curr Drug Targets. 2020; 21(12):1264-1275. DOI: 10.2174/1389450121666200623131200. View